MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Segmentation of neck muscles using ultrasound in cervical dystonia

    A. Siddique, R. Cunningham, M. Silverdale, P. Harding, I. Loram, C. Kobylecki (Salford, United Kingdom)

    Objective: Identify neck muscle boundaries using real-time ultrasound in cervical dystonia and relate imaging data to neck muscle structure and function. Background: Identification of individual…
  • 2018 International Congress

    Who uses guidance techniques for abobotulinumtoxinA injections in the routine management of cervical dystonia?

    V. Misra, R. Trosch, P. Maisonobe, S. Om (London, United Kingdom)

    Objective: Describe the use of injection guidance techniques in different cervical dystonia (CD) patient populations treated in routine practice. Background: The use of injection guidance…
  • 2018 International Congress

    Botulinum toxin A injection for treatment of adductor spasmodic dysphonia under guidance of fiber laryngoscope combined with needle electromyography: 2 case reports

    X. Zhang, Z. Zhang, Y. Pan, L. Jin (Shanghai, China)

    Objective: To report two cases of adductor spasmodic dysphonia that treated with botulinum toxin A under fiber laryngoscope combined with needle electromyography guidance. Background: Spasmodic…
  • 2018 International Congress

    Acoustical characteristics of speech impairment in Primary Generalized Dystonia

    M.C. Cuartero, R. Bertrand, D. Grabli, M. Vidailhet, S. Pinto (Aix-en-Provence, France)

    Objective: To describe acoustic features of speech in Primary Generalized Dystonia (PGD) in order to identify potential subtypes of dysarthria, in line with the previous…
  • 2018 International Congress

    Predictors of alcohol responsiveness in dystonia

    J. Junker, V. Brandt, B. Berman, M. Vidailhet, E. Roze, A. Weissbach, C. Comella, I. Malaty, J. Jankovic, M. LeDoux, A. Berardelli, R. Barbano, S. Reich, J. Perlmutter, H. Jinnah, N. Brueggemann (Luebeck, Germany)

    Objective: To determine predictors of alcohol responsiveness in a large cohort of dystonia patients (Dystonia Coalition Cohort). Background: A notable proportion of dystonia patients show…
  • 2018 International Congress

    Parkinson’s Disease Psychosis Associated Comorbidities, and Mortality in the Medicare Population

    D. Weintraub, A. Willis, P. Torres, A. Shim, J. Norton, K. Liu, G. Demos (Philadelphia, PA, USA)

    Objective: To characterize patients with Parkinson’s disease psychosis (PDP) in the Medicare database, determine comorbidities associated with PDP, and evaluate mortality in PDP compared to…
  • 2018 International Congress

    Emergency and in-patient healthcare utilization in Parkinson’s disease

    M. Mackenzie, G. Al Momen, A. Yu, K. Sundvick, J. Wright, A. Shiu, S. Appel-Cresswell (Vancouver, BC, Canada)

    Objective: To characterize healthcare resource utilization by people with PD by examining emergency room presentations and hospital admissions. Background: PD is a progressive neurodegenerative condition…
  • 2018 International Congress

    Investigating the clinical predictors of depression in Huntington’s disease: An Enroll-HD Database Study

    E. Furr Stimming, G. Colpo, N. Rocha, A. Teixeira (Houston, TX, USA)

    Objective: This study was designed to investigate clinical predictors of depression in subjects with HD. Background: Huntington’s disease (HD) is characterized by motor, cognitive and…
  • 2018 International Congress

    Cerebrospinal fluid flow dynamics in Huntington’s disease evaluated by phase contrast MRI

    F. Rodrigues, L. Byrne, E. De Vita, E. Johnson, N. Hobbs, J. Thornton, R. Scahill, E. Wild (London, United Kingdom)

    Objective: To elucidate the dynamics of CSF flow through the neuraxis in Huntington’s disease (HD) using phase contrast magnetic resonance imaging (PCMRI). Background: HD is…
  • 2018 International Congress

    Effectiveness of peloid therapy in management of Parkinson’s disease (PD): A single center experience

    C.S. Khoo, E. Tokareva, O. Rybalko, I. Sukhareva (Cheras, Malaysia)

    Objective: To evaluate the effectiveness of peloid therapy in patients with Parkinson’s disease (PD). Background: PD is a progressive neurodegenerative movement disorder, which cannot be…
  • « Previous Page
  • 1
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley